Skip to content

Clinical trials

Nephrosis, Lipoid trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nephrosis, Lipoid Country / region: United States Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20091
20101
20131
20161
20194
20201
20211
20225
20232
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11
Completed8
Terminated3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Michigan5
Northwell Health3
Goldfinch Bio, Inc.2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
Aldeyra Therapeutics, Inc.1
Beth Israel Deaconess Medical Center1
Bristol-Myers Squibb1
Children's Hospital of Philadelphia1
Columbia University1
Emory University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nephrosis, Lipoid24
Glomerulosclerosis, Focal Segmental21
Nephrotic Syndrome10
Kidney Diseases8
Glomerulonephritis, Membranous6
Proteinuria5
Diabetic Nephropathies4
Glomerulonephritis, IGA4
Disease2
Nephritis, Hereditary2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.